Coverage of mNEXSPIKE (COVID-19 Vaccine, mRNA) for Medicare Advantage Members (Retroactively effective to August 27, 2025)

Immediately: Billing team should verify that mNEXSPIKE COVID-19 vaccine administration can be billed for Medicare Advantage patients with retroactive coverage back to August 27, 2025. Contact payer for specific billing codes and ensure vaccine inventory and administration procedures are updated. Review any Medicare Advantage claims for this vaccine submitted since August 27 that may have been denied.